High-Throughput Determination of Mode of Inhibition in Lead Identification and Optimization

Abstract

After finishing the primary high-throughput screening, the screening team is often faced with thousands of hits to be evaluated further. Effective filtering of these hits is crucial in identifying leads. Mode of inhibition (MOI) study is extremely useful in validating whether the observed compound activity is specific to the biological target. In this article, the authors describe a high-throughput MOI determination method for evaluating thousands of compounds using an existing screening infrastructure. Based on enzyme or receptor kinetics theory, the authors developed the method by measuring the ratio of IC₅₀ or percent inhibition at 2 carefully chosen substrate or ligand concentrations to define an inhibitor as competitive, uncompetitive, or noncompetitive. This not only facilitates binning of HTS hits according to their MOI but also greatly expands HTS utility in support of the medicinal chemistry team's lead optimization practice. Three case studies are presented to demonstrate how the method was applied successfully in 3 discovery programs targeting either an enzyme or a G-protein-coupled receptor.

Keywords

mode of inhibition competitive noncompetitive high-throughput screening leads identification and optimization

References

Walters WP , Namchuk M : Designing screens: how to make your hits a hit. Nat Rev Drug Discov 2003;2:259-266.

Bleicher KH , Bohm HJ , Muller K , Alanine AI: Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2003;2:369-378.

Copeland RA : Mechanistic considerations in high-throughput screening. Anal Biochem 2003;320:1-12.

McGovern SL , Caselli E , Grigorieff N , Shoichet BK : A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45:1712-1722.

Seidler J , McGovern SL , Doman TN , Shoichet BK : Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 2003;46:4477-4486.

McGovern SL , Shoichet BK : Kinase inhibitors: not just for kinases any-more. J Med Chem 2003;46:1478-1483.

Gumireddy K , Baker SJ , Cosenza SC , John P , Kang AD , Robell KA , et al: A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proc Natl Acad Sci U S A 2005;102:1992-1997.

Combs AP , Yue EW , Bower M , Ala PJ , Wayland B , Douty B , et al: Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics. J Med Chem 2005;48:6544-6548.

Combs AP , Zhu W , Crawley ML , Glass B , Polam P , Sparks RB , et al: Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic. J Med Chem 2006;49:3774-3789.

10.

Park YW , Cummings RT , Wu L , Zheng S , Cameron PM , Woods A , et al: Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104.

11.

Cheng Y-C , Prusoff WH : Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.

12.

Segel IH : Enzyme Kinetics. New York: John Wiley, 1993.

13.

Copeland RA : Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists. New York: John Wiley, 2005.

14.

Kenakin T : A Pharmacology Primer: Theory, Application and Methods. New York: Academic Press, 2006.

15.

McGovern SL , Helfand BT , Feng B , Shoichet BK : A specific mechanism of nonspecific inhibition. J Med Chem 2003;46:4265-4272.

16.

Kiselyov A , Balakin KV , Tkachenko SE , Savchuk NP : Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinases. Mini Rev Med Chem 2006;6:711-717.

17.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.